mem-288
memgen,spdr s&p biotech,ishares biotechnology
['sclc', 'nsclc', 'mem-288', '$ibb', '$xbi']
memgen presents encouraging new clinical data on mem-288 for advanced/metastatic nsclc at asco 2023 annual meeting. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt